alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Independent Auditors' Report


To the Shareholders and Board of Trustees of
Smith Barney Telecommunications Trust:

In planning and performing our audit of the financial statements
of the Smith Barney Telecommunications Income Fund ( Fund ) of
the Smith Barney Telecommunications Trust for the year ended
December 31, 2002, we considered its internal control, including
control activities for safeguarding securities, in order to
determine our auditing procedures for the purpose of expressing
our opinion on the financial statements and to comply with the
requirements of Form N-SAR, not to provide assurance on internal
control.

The management of the Fund is responsible for establishing and
maintaining internal control.  In fulfilling this responsibility,
estimates and judgments by management are required to assess the
expected benefits and related costs of controls.  Generally,
controls that are relevant to an audit pertain to the entity's
objective of preparing financial statements for external purposes
that are fairly presented in conformity with accounting
principles generally accepted in the United States of America.
Those controls include the safeguarding of assets against
unauthorized acquisition, use, or disposition.

Because of inherent limitations in internal control, error or
fraud may occur and not be detected.  Also, projection of any
evaluation of internal control to future periods is subject to
the risk that it may become inadequate because of changes in
conditions or that the effectiveness of the design and operation
may deteriorate.

Our consideration of internal control would not necessarily
disclose all matters in internal control that might be material
weaknesses under standards established by the American Institute
of Certified Public Accountants.  A material weakness is a
condition in which the design or operation of one or more of the
internal control components does not reduce to a relatively low
level the risk that misstatements caused by error or fraud in
amounts that would be material in relation to the financial
statements being audited may occur and not be detected within a
timely period by employees in the normal course of performing
their assigned functions.  However, we noted no matters involving
internal control and its operation, including controls for
safeguarding securities, that we consider to be material
weaknesses as defined above as of December 31, 2002.

This report is intended solely for the information and use of
management and the Board of Trustees of the Fund and the
Securities and Exchange Commission and is not intended to be and
should not be used by anyone other than these specified parties.



                                             KPMG LLP
New York, New York
February 12, 2003
xml version="1.0" encoding="UTF-8"?


C\_2018185EN.01000401.xml


| | | | |
| --- | --- | --- | --- |
| 30.5.2018 | EN | Official Journal of the European Union | C 185/4 |

---

Prior notification of a concentration

(Case M.8674 — BASF/Solvay’s Polyamide Business)

(Text with EEA relevance)

(2018/C 185/05)

1.

On 22 May 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2018185EN.01000401-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | BASF SE (‘BASF’, Germany), |

| | |
| --- | --- |
| — | Solvay’s worldwide polyamide activities (‘the Business’ Belgium). |

BASF acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of the Business.

The concentration is accomplished by way of purchase of shares. BASF and Solvay entered into a share purchase agreement on 22 December 2017.

2.

The business activities of the undertakings concerned are:

—   for BASF: chemicals, performance products, functional materials & solutions, agricultural solutions and oil & gas. BASF is active in the Polyamide value chain, in particular in the production of HMD, Adipic Acid, AH-Salt, Polyamide Base Polymer (PA 6.6) and Polyamide Engineering Plastic (PA 6.6 EP),

—   for the Business: polyamides and intermediates (also referred as ‘P&I’), engineering plasticss. The Business is also active in the Polyamide value chain, in particular in the production of ADN, HMD, Adipic Acid, AH-Salt, Polyamide Base Polymer (PA 6.6) and Polyamide Engineering Plastic (PA 6.6 EP).

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.8674 — BASF/Solvay

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| |
| --- |
| Email: COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2018185EN.01000401-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

---
Jason Brady SAIN, Petitioner, v. OKLAHOMA.

No. 18-9566

Supreme Court of the United States.

October 7, 2019

Petition for writ of certiorari to the Court of Criminal Appeals of Oklahoma denied.
October 3, 1997
Smith Barney Aggressive Growth Fund Inc.
388 Greenwich Street
New York, New York 10013

                   Re:  Rule 24f-2 Notice
                              
Gentlemen:

    In connection with the filing by Smith Barney Aggressive
Growth Fund Inc., a Maryland corporation (the "Fund"), of a
Notice (the "Notice"), pursuant to Rule 24f-2 (the "Rule")
under the Investment Company Act of 1940, as amended (the
"Act"), for the Fund's fiscal year ended August 31, 1997,
the undersigned hereby provides the legal opinion required
by that Rule.

     In accordance with the Rule, the Fund has registered an
indefinite number of shares of common stock, $0.01 par
value, under the Securities Act of 1933, as amended (the
"1933 Act"). The purpose of the Notice is to make definite
the registration of 20,455,979 shares of the Fund (the
"Shares") sold in reliance upon the Rule during the fiscal
year ended August 31, 1997.

     The undersigned is Associate General Counsel of Smith
Barney Mutual Funds Management Inc., the Fund's Investment
Adviser and Administrator, and in such capacity, from time
to time and for certain purposes, acts as counsel to the
Fund. He has examined copies of the Fund's Articles of
Incorporation, its By-Laws, resolutions adopted by its Board
of Directors, and such other records and documents as have
been deemed necessary for purposes of this opinion.
Furthermore, he has examined a Certificate of the Controller
of the Fund to the effect that the Fund received the cash
consideration for each of the Shares in accordance with the
aforementioned organizational documents and resolutions.

     On the basis of the foregoing, and assuming all of the
Shares were sold in accordance with the terms of the Fund's
Prospectus in effect at the time of sale, he is of the
opinion that the Shares have been duly authorized and
validly issued and are fully paid and non-assessable.  This
opinion is for the limited purposes expressed above and
should not be deemed to be an expression of opinion as to
compliance with the 1933 Act, the 1940 Act or applicable
State "blue sky" laws in connection with the sales of the
Shares.


                                        Very truly yours,


                                        Robert Nelson
                                        Associate General
                                        Counsel
                                        Smith Barney Mutual
Funds
Management Inc.
[Federal Register Volume 87, Number 108 (Monday, June 6, 2022)]
[Notices]
[Pages 34278-34279]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-12005]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; RFA DK21-012 SBIR 
Review.
    Date: June 29, 2022.
    Time: 1:00 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NIDDK, NIH, 6707 Democracy Blvd., Bethesda, MD 20892 
(Virtual Meeting).
    Contact Person: Ann A. Jerkins, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-2242, <a href="/cdn-cgi/l/email-protection#f69c93849d9f988597b6989f92929dd8989f9ed8919980"><span class="__cf_email__" data-cfemail="4f252a3d2426213c2e0f21262b2b246121262761282039">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research;

[[Page 34279]]

93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney 
Diseases, Urology and Hematology Research, National Institutes of 
Health, HHS)

    Dated: May 31, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-12005 Filed 6-3-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
UNITED STATES, Petitioner v. Dominic Ladale WALTON.

No. 19-151

Supreme Court of the United States.

November 25, 2019

On petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit. Motion of respondent for leave to proceed *in forma pauperis* and petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit granted. Judgment vacated, and case remanded to the United States Court of Appeals for the Fifth Circuit for further consideration in light of *Quarles* v. *United States* , 587 U.S. ----, 139 S.Ct. 1872, 204 L.Ed.2d 200 (2019).
Charles D. SCOVILLE, Petitioner, v. SECURITIES AND EXCHANGE COMMISSION.

No. 18-1566

Supreme Court of the United States.

November 4, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Tenth Circuit denied.
Anne K. BLOCK, Petitioner v. WASHINGTON STATE BAR ASSOCIATION, et al.

No. 19-291

Supreme Court of the United States.

December 9, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
IB 

Union Calendar No. 91 

113TH CONGRESS 

1ST SESSION H. R. 1171 

[Report No. 113–126] 

To amend title 40, United States Code, to improve veterans service 

organizations access to Federal surplus personal property. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 14, 2013 

Mr. BENISHEK (for himself, Ms. BROWNLEY of California, Mr. ROE of Tennessee, and Mr. O’ROURKE) introduced the following bill; which was referred to the Committee on Oversight and Government Reform 

JUNE 25, 2013 

Additional sponsors: Mr. RUIZ, Mr. ENYART, Mr. BENTIVOLIO, and Mr. 

COTTON

JUNE 25, 2013 

Committed to the Committee of the Whole House on the State of the Union 

and ordered to be printed 


sroberts on DSK5SPTVN1PROD with BILLS
2 

•HR 1171 RH

A BILL 

To amend title 40, United States Code, to improve veterans 

service organizations access to Federal surplus personal 

property. 


sroberts on DSK5SPTVN1PROD with BILLS
3 

•HR 1171 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Formerly Owned Re5 sources for Veterans to Express Thanks for Service Act 

6 of 2013’’ or the ‘‘FOR VETS Act of 2013’’. 

7 SEC. 2. VETERANS ACCESS TO FEDERAL EXCESS AND SUR8 PLUS PERSONAL PROPERTY. 

9 Section 549(c)(3) of title 40, United States Code, is 

10 amended— 

11 (1) in subparagraph (A), by striking ‘‘or’’ at 

12 the end; 

13 (2) in subparagraph (B)— 

14 (A) in clause (viii), by adding ‘‘or’’ at the 

15 end; and 

16 (B) by striking clause (x); and 

17 (3) by adding at the end the following: 

18 ‘‘(C) for purposes of providing services to 

19 veterans (as defined in section 101 of title 38), 

20 to an organization whose— 

21 ‘‘(i) membership comprises substan22 tially veterans; and 

23 ‘‘(ii) representatives are recognized by 

24 the Secretary of Veterans Affairs under 

25 section 5902 of title 38.’’. 


sroberts on DSK5SPTVN1PROD with BILLS
Union Calendar No. 91 

113TH CONGRESS 

1ST SESSION H. R. 1171 

[Report No. 113–126] 

A BILL 

To amend title 40, United States Code, to improve 

surplus personal property. veterans service organizations access to Federal 

JUNE 25, 2013 

Committed to the Committee of the Whole House on the 

State of the Union and ordered to be printed 


sroberts on DSK5SPTVN1PROD with BILLS
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; RFA-NS-22-037: HEAL Initiative: Advancing Health Equity in Pain and Comorbidities.                    

*Date:*                         July 19, 2022.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Randolph Christopher Capps, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1009J, Bethesda, MD 20892, (301) 435-1042,                         *cappsrac@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: June 10, 2022.

Tyeshia M. Roberson-Curtis,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-12951 Filed 6-15-22; 8:45 am]

BILLING CODE 4140-01-P
March 1, 2001

Mr. Don Samaria
The Bentley Group
2235 Camino del Vecino
Alpine, CA  91901

Dear Don:

This letter confirms the
arrangement that we entered into with you early last month to perform certain
investor and market relations functions on behalf of EarthShell Corporation. The
objectives of your consulting services has been to assist EarthShell to heighten
market awareness, to broaden retail ownership and to increase trading volumes in
order to minimize share price volatility. We previously forwarded to you product
samples and promotional literature along with a list of our shareholders and
other contacts who have expressed an interest in the Company, which should be
useful in communicating the EarthShell story to your investment community
contacts. Please continue to keep me apprised in writing of market attitudes
toward ERTH every day or two, and let me know how we can better interface with
the market.

We agreed to pay you a
fixed fee for your consulting services of 150,000 shares of ERTH stock, plus a
fixed amount of $50,000 for direct expenses. In consideration for your work over
the past several weeks, upon receipt of this countersigned letter, we will
deliver to you the first installment of 75,000 shares of ERTH stock and our
check for your expenses of $50,000. The second installment of your service fee
will be made in the form of 75,000 shares of ERTH on or before March 15, 2001.

If this letter is
consistent with your understanding, please countersign and return to me.

Sincerely,

/s/ Simon Hodson

Simon Hodson
President and Chief Executive Officer

AGREED AND ACCEPTED:

`/s/ Don Samaria                                     
Don Samaria                         Date`
Exhibit 32.1

                        CERTIFICATION OF PERIODIC REPORT

Pursuant to 18 U.S.C.  Section 1350,  as adopted  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, each of the undersigned officers of tds (Telemedine)
Inc. (the "Company"), certifies that:

     1.   The  Quarterly  Report on Form  10-QSB of the  Company for the Quarter
          ended  September  30,  2007 (the  "Report")  fully  complies  with the
          requirements of Section 13(a) or 15(d) of the Securities  Exchange Act
          of 1934 (15 U.S.C. 78m or 78o(d)); and

     2.   The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.





Dated: November 14, 2007          /S/           DAVID WINSNESS
                                  ----------------------------
                                                DAVID WINSNESS
                                                Chief Executive Officer


                                  /S/           KEVIN KREISLER
                                  ----------------------------
                                                KEVIN KREISLER
                                                Chief Financial Officer


This  certification  is made solely for the purpose of 18 U.S.C.  Section  1350,
subject  to the  knowledge  standard  contained  therein,  and not for any other
purpose.
Quintin WRIGHT, Petitioner, v. UNITED STATES.

No. 19-7003.

Supreme Court of the United States.

April 20, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000797480
<NAME> SMITH BARNEY SECTOR SERIES
<SERIES>
   <NUMBER>002
   <NAME>SMITH BARNEY FINANCIAL SERVICES FUND

<S>                         <C>
<PERIOD-TYPE>              8 Mos
<FISCAL-YEAR-END>                 OCT-31-2001
<PERIOD-END>                      OCT-31-2000
<INVESTMENTS-AT-COST>             62,961,866
<INVESTMENTS-AT-VALUE>            73,854,933
<RECEIVABLES>                      7,001,724
<ASSETS-OTHER>                             0
<OTHER-ITEMS-ASSETS>                     238
<TOTAL-ASSETS>                    80,856,895
<PAYABLE-FOR-SECURITIES>           6,839,347
<SENIOR-LONG-TERM-DEBT>                    0
<OTHER-ITEMS-LIABILITIES>                  0
<TOTAL-LIABILITIES>                6,839,347
<SENIOR-EQUITY>                            0
<PAID-IN-CAPITAL-COMMON>          60,555,611
<SHARES-COMMON-STOCK>              1,952,207
<SHARES-COMMON-PRIOR>                      0
<ACCUMULATED-NII-CURRENT>             18,454
<OVERDISTRIBUTION-NII>                     0
<ACCUMULATED-NET-GAINS>            2,373,976
<OVERDISTRIBUTION-GAINS>                   0
<ACCUM-APPREC-OR-DEPREC>          10,887,257
<NET-ASSETS>                      73,835,299
<DIVIDEND-INCOME>                    664,565
<INTEREST-INCOME>                     41,152
<OTHER-INCOME>                             0
<EXPENSES-NET>                       687,263
<NET-INVESTMENT-INCOME>               18,454
<REALIZED-GAINS-CURRENT>           2,373,976
<APPREC-INCREASE-CURRENT>         10,887,258
<NET-CHANGE-FROM-OPS>             13,279,688
<EQUALIZATION>                             0
<DISTRIBUTIONS-OF-INCOME>                  0
<DISTRIBUTIONS-OF-GAINS>                   0
<DISTRIBUTIONS-OTHER>                      0
<NUMBER-OF-SHARES-SOLD>           67,499,965
<NUMBER-OF-SHARES-REDEEMED>       (6,944,354)
<SHARES-REINVESTED>                        0
<NET-CHANGE-IN-ASSETS>            73,835,299
<ACCUMULATED-NII-PRIOR>                    0
<ACCUMULATED-GAINS-PRIOR>                  0
<OVERDISTRIB-NII-PRIOR>                    0
<OVERDIST-NET-GAINS-PRIOR>                 0
<GROSS-ADVISORY-FEES>                260,242
<INTEREST-EXPENSE>                         0
<GROSS-EXPENSE>                      866,806
<AVERAGE-NET-ASSETS>              19,969,650
<PER-SHARE-NAV-BEGIN>                  11.40
<PER-SHARE-NII>                        (0.01)
<PER-SHARE-GAIN-APPREC>                 0.00
<PER-SHARE-DIVIDEND>                    0.00
<PER-SHARE-DISTRIBUTIONS>               0.00
<RETURNS-OF-CAPITAL>                    0.00
<PER-SHARE-NAV-END>                    15.81
<EXPENSE-RATIO>                         2.25
[AVG-DEBT-OUTSTANDING]                     0
[AVG-DEBT-PER-SHARE]                       0



</TABLE>